1. Home
  2. XERS vs MNTK Comparison

XERS vs MNTK Comparison

Compare XERS & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • MNTK
  • Stock Information
  • Founded
  • XERS 2005
  • MNTK 1980
  • Country
  • XERS United States
  • MNTK United States
  • Employees
  • XERS N/A
  • MNTK N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • MNTK Natural Gas Distribution
  • Sector
  • XERS Health Care
  • MNTK Utilities
  • Exchange
  • XERS Nasdaq
  • MNTK Nasdaq
  • Market Cap
  • XERS 628.7M
  • MNTK 622.2M
  • IPO Year
  • XERS 2018
  • MNTK 2021
  • Fundamental
  • Price
  • XERS $5.07
  • MNTK $1.76
  • Analyst Decision
  • XERS Strong Buy
  • MNTK Hold
  • Analyst Count
  • XERS 6
  • MNTK 3
  • Target Price
  • XERS $6.25
  • MNTK $3.33
  • AVG Volume (30 Days)
  • XERS 2.1M
  • MNTK 218.8K
  • Earning Date
  • XERS 05-08-2025
  • MNTK 05-08-2025
  • Dividend Yield
  • XERS N/A
  • MNTK N/A
  • EPS Growth
  • XERS N/A
  • MNTK N/A
  • EPS
  • XERS N/A
  • MNTK 0.05
  • Revenue
  • XERS $222,551,000.00
  • MNTK $179,552,000.00
  • Revenue This Year
  • XERS $33.96
  • MNTK $4.25
  • Revenue Next Year
  • XERS $19.87
  • MNTK $23.36
  • P/E Ratio
  • XERS N/A
  • MNTK $35.33
  • Revenue Growth
  • XERS 29.88
  • MNTK N/A
  • 52 Week Low
  • XERS $2.03
  • MNTK $1.75
  • 52 Week High
  • XERS $6.07
  • MNTK $6.22
  • Technical
  • Relative Strength Index (RSI)
  • XERS 54.35
  • MNTK 36.61
  • Support Level
  • XERS $4.71
  • MNTK $1.81
  • Resistance Level
  • XERS $5.09
  • MNTK $1.97
  • Average True Range (ATR)
  • XERS 0.22
  • MNTK 0.14
  • MACD
  • XERS -0.00
  • MNTK -0.02
  • Stochastic Oscillator
  • XERS 58.93
  • MNTK 0.89

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About MNTK Montauk Renewables Inc.

Montauk Renewables Inc is a United States-based renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments: Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.

Share on Social Networks: